Cat's Claw
Best-in-class: Cat's Claw
An Amazonian bark used for immune modulation and joint/inflammatory support.
Cat's Claw quick facts
| Suggested dose | 250–500 mg extract daily. |
| How often | Daily |
| Who it's for | Joint/inflammatory and immune support. |
The chemotype issue is the thing most products ignore: tetracyclic alkaloids antagonize the pentacyclic ones, so an unspecified extract may contain a mixture working against itself. Some trial evidence in osteoarthritis and rheumatoid arthritis. Because it is immunomodulatory it warrants caution in autoimmunity and after transplant, and it inhibits CYP3A4.
How Cat's Claw actually works
Oxindole alkaloids with immunomodulatory activity and quinovic acid glycosides with anti-inflammatory effects through NF-kB inhibition. Two chemotypes exist — pentacyclic and tetracyclic — and they have opposing effects on the immune system, which makes chemotype specification genuinely important rather than pedantic.
Where to get Cat's Claw
Find Cat's Claw on iHerb →The evidence for Cat's Claw
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs show reduced joint pain in osteoarthritis/rheumatoid arthritis; immune-modulating activity.
- Anti-inflammatory alkaloids drive the effects.
📊 Correlative data
- Long use by Amazonian peoples, particularly the Asháninka, for inflammatory and digestive complaints. Traditional preparation was a bark decoction, which differs from most modern extracts.
🧪 Theoretical / extrapolated benefits
- Traditional immune and anti-inflammatory use aligns with the joint findings.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Cat's Claw actually does
The interesting chemistry in Uncaria tomentosa is a set of oxindole alkaloids, and they come in two families that a bottle almost never distinguishes. Pentacyclic oxindole alkaloids — pteropodine, isopteropodine, mitraphylline, isomitraphylline, uncarine F, speciophylline — are the group the rheumatology trial deliberately selected for Mur 2002. Tetracyclic oxindole alkaloids, principally rhynchophylline and isorhynchophylline, are a different pharmacology in the same species, and plants of the two chemotypes are indistinguishable in the field.
The mechanism the trials rest on is transcriptional. A bark extract at 100 micrograms per milliliter attenuated peroxynitrite-induced apoptosis in HT29 cells and inhibited lipopolysaccharide-induced inducible nitric oxide synthase expression and NF-kappaB activation in RAW 264.7 macrophages Sandoval-Chacón 1998. So the proposed action is upstream of the enzyme rather than on it: less NF-kappaB reaching the iNOS promoter, therefore less iNOS protein, therefore less nitric oxide and less peroxynitrite in an inflamed tissue.
The number in that sentence is the one to hold onto. One hundred micrograms per milliliter is a concentration of crude bark extract chosen by an experimenter and applied to cells in a dish. No study has ever measured the plasma concentration of any oxindole alkaloid in a person taking a supplement, so the distance between the dish and the joint is unquantified in both directions — nobody can say the dose is too low, and nobody can say it is enough.
And there is a second, entirely separate mechanism with clinical consequences. Cat's claw inhibits CYP3A4 in people: adding it raised exposure to the protease inhibitors atazanavir, ritonavir and saquinavir in a documented clinical interaction López Galera 2008. That is not a theoretical enzyme note. CYP3A4 metabolizes a large share of everything in a medicine cabinet, and this is the best-evidenced pharmacological effect the plant has.
Cell, rodent, human — and where it stops
In cells. HT29 intestinal cells and RAW 264.7 macrophages, bark extract at 100 µg/mL, NF-kappaB and iNOS suppressed, apoptosis from peroxynitrite attenuated Sandoval-Chacón 1998.
In knee osteoarthritis. Forty-five patients: 30 took freeze-dried cat's claw at 500 mg daily and 15 took placebo for 4 weeks. Pain during activity fell significantly within the first week Piscoya 2001. Read the title of that paper before you use it, though — the species was Uncaria guianensis.
In rheumatoid arthritis. Forty patients with active disease took an extract from the pentacyclic alkaloid chemotype of Uncaria tomentosa or placebo. Over 24 weeks the number of painful joints fell by 53.2% against 24.1% on placebo, p = 0.044 Mur 2002.
The obstacle is the form, and it applies twice. The osteoarthritis result belongs to a different species Piscoya 2001. The rheumatoid result belongs to a defined chemotype of the species on the label Mur 2002. The bottle in your hand states neither — it says Uncaria tomentosa and stops. Both trials are also in people with a diagnosed arthritis, which is a population with inflamed joints and room to improve; there is no trial of cat's claw in a well person for anything.
And the timescales do not match the shelf. The rheumatoid result took 24 weeks to accumulate on a joint count Mur 2002. A four-week trial of a capsule, which is what most people run, has not tested the thing that worked.
Cat's Claw — which form, and does it matter
Species first. At least two plants are sold as cat's claw. Uncaria tomentosa is what the catalog card names and what the rheumatoid trial used. Uncaria guianensis is what the osteoarthritis trial used Piscoya 2001. They are different species with different alkaloid profiles, and a page that cites the knee-pain result under a tomentosa heading has made a substitution silently. This site's own card does exactly that, and it is worth correcting rather than repeating.
Chemotype second, and it is the one nobody prints. The rheumatoid extract was selected for pentacyclic alkaloids Mur 2002. A standardization claim of “3% oxindole alkaloids” does not say what the pentacyclic-to-tetracyclic split is, which means two bottles with identical label claims can be pharmacologically different preparations.
Preparation third. The traditional use this plant's reputation comes from was a bark decoction — water, heat, hours. A hydroalcoholic 250 mg capsule extracts a different set of compounds in different proportions, and the freeze-dried material in the osteoarthritis trial is a third thing again Piscoya 2001. The traditional safety record belongs to the decoction and does not automatically transfer to a concentrated extract.
What to demand: the species in Latin, the chemotype, and the plant part. Three lines of text, and their absence is the single best reason to put a bottle down.
What would have to be true, and how you would know it was not
1. The prediction that cuts against the product. If the mechanism is NF-kappaB suppression upstream of iNOS Sandoval-Chacón 1998, an anti-inflammatory effect should show in an inflammatory marker. Predict hs-CRP does not fall measurably at 250–500 mg/day over 8 weeks in someone whose baseline CRP is already under 1 mg/L — there is nothing to suppress. Predict it may fall from an elevated baseline. That distinction is testable for the price of one blood test and it decides whether this product has anything to offer you specifically.
2. The duration prediction. The joint-count effect took 24 weeks Mur 2002. Predict nothing interpretable at 4 weeks, and treat a four-week course that “did nothing” as an untested course rather than a negative result.
3. The false positive that will fool you, and it is a real danger. Cat's claw inhibits CYP3A4 López Galera 2008. If you feel different after adding it while taking a statin, a calcium blocker, a benzodiazepine or a direct oral anticoagulant, the parsimonious explanation is a raised drug level, not an anti-inflammatory effect. That reading is checkable: the symptoms of a raised statin level — new muscle aching — look nothing like the joint relief you were hoping for, and a CK will separate them.
What nobody has tested yet
Pentacyclic against tetracyclic has never been run in a person. The entire justification for the rheumatoid extract is that it was chemotype-selected Mur 2002, and no clinical study has ever compared the two chemotypes head to head on any endpoint. Both are commercially obtainable. The experiment has been available for twenty years.
There is no human pharmacokinetic study of any oxindole alkaloid after an oral supplement dose. No Cmax, no half-life, no tissue data. That is why the 100 µg/mL in the cell work Sandoval-Chacón 1998 cannot be compared to anything a capsule does.
The CYP3A4 interaction has never been quantified. It is documented as a clinical event López Galera 2008 and has never been put through a formal probe study with a standard substrate. The single most safety-relevant property of this plant is known only as a case report.
And the two arthritis results have never been put in the same protocol. U. guianensis and pentacyclic U. tomentosa, same patients, same scale, would say whether these are one effect or two, and whether the species on the label matters at all.
Cat's Claw — its own safety story, not its category's
The interaction that actually matters is CYP3A4, and it is documented in humans rather than predicted. Exposure to atazanavir, ritonavir and saquinavir rose when cat's claw was added López Galera 2008. CYP3A4 clears simvastatin and atorvastatin, most calcium channel blockers, many benzodiazepines, tacrolimus, ciclosporin, apixaban and rivaroxaban. Inhibiting it raises the level of every one of those, which means the harm here is an overdose of a drug you were taking correctly.
This is the worst product on this shelf for a transplant recipient, and for two independent reasons at once. It is sold as an immune stimulant, which runs against the purpose of the regimen; and it inhibits the enzyme that clears tacrolimus and ciclosporin López Galera 2008, which changes their blood levels. Either alone would be a reason to decline. Together they are a mechanism for rejection and a mechanism for toxicity in the same capsule.
Pregnancy is a hard no. This bark has traditional contraceptive and abortifacient use, which is not a fringe claim about it but part of its documented ethnobotany.
The ceiling nobody has set. No upper limit exists. The longest controlled human exposure is 24 weeks Mur 2002; the osteoarthritis trial ran 4 Piscoya 2001. Beyond six months there is no data at all, in a product people take indefinitely for joints.
Who should not take it: anyone on a CYP3A4-cleared medicine without telling their prescriber, anyone after a transplant, anyone pregnant, and anyone whose morning stiffness lasts an hour — because that pattern is an inflammatory arthritis that has a diagnosis and a treatment, and 24 weeks of bark is a long time to spend not getting one.
Sources read for this page
- Sandoval-Chacón M, et al. Antiinflammatory actions of cat's claw: the role of NF-kappaB. Alimentary Pharmacology & Therapeutics 1998 · PMID 9882039
- Piscoya J, et al. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflammation Research 2001 · PMID 11603848
- Mur E, et al. Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of uncaria tomentosa for the treatment of rheumatoid arthritis. Journal of Rheumatology 2002 · PMID 11950006
- López Galera RM, et al. Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir. European Journal of Clinical Pharmacology 2008 · PMID 18712519
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: How often you reach for something else. Count the days per week you take a painkiller or anti-inflammatory for the joint in question, and the tasks you avoided because of it — stairs, a jar, an hour at a keyboard. Rescue-medication counts are what joint trials use when they want an outcome that cannot be talked into existing.
- How long before it means anything: Eight weeks. Joint pain swings on a scale of weeks with weather, load and sleep, so a fortnight of feeling looser sits inside the normal range of a joint that has not changed at all.
- What will fool you: The flare you were in when you bought it. Inflammatory joint pain regresses toward its own average, and the worse the week you started, the better the next month looks. Two specifics for this bark: it interacts with immunosuppressants and blood pressure medication, so it is not a free addition if you take either — and a joint that is hot, swollen, or stiff for an hour every morning is an inflammatory arthritis question for a doctor, not a herb.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Cat's Claw — safety & side effects
- GI upset, headache and dizziness.
- Inhibits CYP3A4 — raises levels of a range of medications including protease inhibitors. May lower blood pressure.
- Avoid in pregnancy (traditional contraceptive and abortifacient use), and with autoimmune disease or after a transplant.
The same on every page it applies to. Read it here; it is not repeated research.
- Immunostimulant — caution with autoimmune disease and with immunosuppressants, including after a transplant. Stimulating an immune system that is already attacking you is the wrong direction, and 'natural' does not change that.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Cat's Claw in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Cat's Claw
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | White cells and their differential — the actual immune measurement |
| Vitamin D (25-Hydroxy) | The deficiency with the most credible immune evidence |
| Zinc, Plasma | Real deficiency impairs immune function; excess doesn't help |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney, since 'detox' is what those two organs do |
The Frequent Illness & Immune Resilience panel covers these in one order — 8 markers, $97.65 with the discount applied.
Check results you already have → · All 103 markers A–Z
Cat's Claw — frequently asked questions
What is Cat's Claw?
An Amazonian bark used for immune modulation and joint/inflammatory support.
What is the suggested dose of Cat's Claw?
250–500 mg extract daily. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Cat's Claw dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Cat's Claw?
Coach Cam sources Cat's Claw from vetted, top-rated brands on iHerb — use the buy link on this page.
What Cat's Claw is used for
Cat's Claw appears under 1 goal in the goal router.
Related Immune & Detox supplements
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.